Scala Med
Scala Med operates the Outcomes clinical pharmacy platform, connecting payers, pharma, and providers to a network of 48,000+ pharmacies and 70 million+ patients via subscription software (Rx30, ComputerRx), telepharmacy, and clinical services revenue streams.
- Company typePrivate
- Founded2017
- HeadquartersHouston, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Scala Med does
Scala Med, founded in 2017 and headquartered in Houston, is positioned as a prescription-focused healthcare technology company described on its website as "the future of prescriptions." The aggregated dataset, however, extensively describes the Outcomes platform — a clinical pharmacy care ecosystem connecting payers, pharmaceutical manufacturers, and providers to what the company characterizes as the largest pharmacy network in healthcare, spanning 48,000+ pharmacies, 68,000+ practice sites, and 70 million+ patients. The platform's core products include the flagship Outcomes and Outcomes Premium clinical platforms, the Rx30 and ComputerRx pharmacy management systems, plus modular add-ons covering Patient Engagement, Vaccine Registry, TelePharm (HIPAA-compliant cloud-based telepharmacy), PillCount, Virtual Verification, Specialty pharmacy, IVR, and Reconciliation. The technical architecture is cloud-based and HIPAA-compliant, with HITRUST CSF certification supporting healthcare data security requirements.
Business model mechanics span four revenue streams: subscription/recurring revenue from pharmacy management software (Rx30, ComputerRx, Outcomes platforms); transaction-based clinical services revenue (with $88.6 million paid to pharmacies in 2026 and $181 million / $190 million paid through the platform in 2024 / 2025 respectively); subscription-based payer solutions for health plans managing adherence and therapy outcomes; and subscription-based pharma solutions enabling patient access and engagement across the therapy journey. Go-to-market is sales-led with quote-based enterprise pricing — no public price list exists — and distribution combines direct enterprise sales, a self-serve platform access portal, and an Integration Partners channel program. The company is privately held with no disclosed parent or recent institutional funding beyond a $1.1 million round from Macdoch Ventures in 2019 and a 2020 gbeta accelerator participation; Tal Rapke is identified as CEO and founder.
Scala Med firmographics
Firmographics- Name
- Scala Med
- Legal name
- Outcomes
- Website
- https://scalamed.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Scala Med operates the Outcomes clinical pharmacy platform, connecting payers, pharma, and providers to a network of 48,000+ pharmacies and 70 million+ patients via subscription software (Rx30, ComputerRx), telepharmacy, and clinical services revenue streams.
- Ownership category
- akta.pro rank
Scala Med industry classification
Industry- Product category
- Pharmacy Management Software
- SIC
- Services-Health Services (8000), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
- akta.pro secondary industries
- Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH), Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
Keywords
Where Scala Med is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Markets served
Scala Med business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Platform/Subscription Revenue: Pharmacy management software subscriptions including Rx30, ComputerRx, Outcomes, and Outcomes Premium products. Pharmacies pay for platform access and management tools.
- Clinical Services Revenue: Payment to pharmacies for medication therapy management and clinical services. In 2026, $88,561,589 was paid directly to pharmacies through the platform. Total pharmacy earnings were $181MM in 2024 and $190MM in 2025.
- Payer Solutions: Solutions for health plans and payers to optimize health outcomes through pharmacist expertise and patient therapy/adherence management
- Pharma Solutions: Patient engagement solutions for pharmaceutical manufacturers to access and engage patients from first experience through course of therapy
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Quote-based enterprise pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Scala Med product offering
Product offeringCore offering
Scala Med (operating as Outcomes) provides a unified clinical pharmacy care ecosystem platform that connects payers, pharmaceutical manufacturers, and providers to a pharmacy network of 48K+ pharmacies and 68K+ practice sites. The platform delivers pharmacy management software (Rx30, ComputerRx), medication therapy management, patient engagement, telepharmacy, virtual verification, immunization registry, and clinical reconciliation tools used to manage dispensing, optimize clinical opportunities, and drive medication adherence across 70M+ patients.
Product overview
Outcomes is a unified clinical pharmacy care ecosystem platform that connects payers, pharma, and providers to the largest pharmacy network. The platform operates as a core platform (Outcomes) with multiple integrated modules and sub-branded pharmacy management solutions. The product portfolio includes core clinical platforms (Outcomes, Outcomes Premium), pharmacy management systems (Rx30, ComputerRx), patient engagement tools (Patient Engagement, Vaccines), telepharmacy solutions (TelePharm, Virtual Verification), inventory management (PillCount), communications (IVR), specialty services, and reconciliation tools. The ecosystem manages dispensing, medication therapy management, and patient engagement, connecting 70M+ patients across 48K+ pharmacies and 68K+ practice sites.
Differentiator
Problem solved
Functional benefit
Brands
- OutcomesOne: Pharmacy management platform for optimizing pharmacy operations, maximizing clinical opportunities, diversifying revenue, and engaging patients.
- Outcomes Premium
- Rx30
- ComputerRx
- Patient Engagement
- Vaccines
- Telepharm
- PillCount
- Virtual Verification
- Specialty
- IVR
- Reconciliation
Products and services
- Outcomes Clinical pharmacy platform that connects payers, pharma, and providers to a pharmacy network, providing patient engagement, intervention, and adherence solutions for independent and chain pharmacies.
- Outcomes Premium Enhanced version of the Outcomes platform with additional features and capabilities for pharmacy operations, targeted at pharmacies seeking expanded clinical and operational functionality.
- Rx30 Pharmacy management software with streamlined workflows and automation features for prescription processing and integrated POS solutions, sold to independent and chain pharmacies.
- ComputerRx Pharmacy management software solution for prescription processing and pharmacy operations, used by independent pharmacies.
- Patient Engagement Digital communication platform enabling pharmacies, manufacturers, and payers to stay connected with patients through two-way messaging and targeted adherence plans.
- Vaccines (Vaccine Registry) Vaccine registry solution for tracking and managing patient immunization records across pharmacy locations.
- TelePharm HIPAA-compliant cloud-based telepharmacy platform providing remote counseling and virtual verification capabilities for pharmacies.
- Specialty Pharmacy Specialty pharmacy services and solutions for managing complex medications within the Outcomes suite.
- IVR (Interactive Voice Response) Clinically integrated cloud-based interactive voice response solution compatible with PSTN and IP networks, used for patient communications by pharmacies.
Quantifiable outcome
- Pharmacies earned $181MM through Outcomes in 2024 and $190MM in 2025
- +1 more outcomes
Companies that use Scala Med
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles3 records
Scala Med technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Scala Med partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Integration PartnerscoreOutcomes maintains an Integration Partners program connecting pharmacy management software with complementary healthcare technology solutions. The platform supports various integrations including prescription processing, POS solutions, and clinical services.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Scala Med competitors and assessment
Company assessmentDirect peers
- PioneerRx: PioneerRx is a pharmacy management software platform for independent pharmacies, offering dispensing, clinical services, and patient engagement. It directly competes with Outcomes' Rx30 and ComputerRx pharmacy management products for the same SMB pharmacy customers.
- BestRx: BestRx is a pharmacy management system for independent and small-chain pharmacies, providing dispensing, workflow, and clinical documentation. It competes head-to-head with Rx30 and ComputerRx for independent pharmacy management software contracts.
- PrescribeWellness: PrescribeWellness (mentioned in Outcomes' own customer testimonials) provides patient engagement, refill reminders, and adherence programs to community pharmacies. It is a direct competitor on medication adherence, patient communication, and pharmacy patient engagement modules.
- AdhereHealth: AdhereHealth is a medication adherence platform serving health plans and pharma with pharmacist-led interventions. It directly overlaps with Outcomes' payer and pharma solutions, competing for the same adherence, MTM, and Star Ratings improvement contracts.
Emerging players
- Omnicell: Omnicell provides pharmacy automation, medication management, and clinical workflow software to health systems and retail pharmacies. It competes with Outcomes on the pharmacy operations and clinical services technology layers, with deeper health system penetration.
- DocStation: DocStation is a clinical platform enabling pharmacists to deliver and bill for MTM, adherence, and clinical services to health plans. It competes with Outcomes on the payer-facing clinical services and pharmacist-patient engagement layer, with a more focused, modern product.
Broad incumbents
- Surescripts: Surescripts operates the largest nationwide ePrescribing network connecting pharmacies, payers, and prescribers. It overlaps with Outcomes on the clinical care ecosystem, adherence programs, and pharmacy-pharma connectivity, and is a foundational infrastructure layer for U.S. prescriptions.
- CoverMyMeds (McKesson): CoverMyMeds, owned by McKesson, is the dominant ePrescribing and prior authorization network serving pharmacies, payers, and pharma. It competes with Outcomes on the medication adherence, clinical services, and pharmacy workflow layers, with substantially greater resources and broader payer integration.
- Walgreens Boots Alliance (VillageMD): Walgreens, through VillageMD and its pharmacy operations, offers clinical services, patient engagement, and adherence programs at scale. As a retail pharmacy incumbent, it represents both a potential partner and a competitive threat to the independent-pharmacy-focused Outcomes model.
- CVS Health (Caremark): CVS Health, through Caremark and MinuteClinic, operates its own pharmacy technology, clinical services, and adherence programs. It is a broad incumbent that competes for both payer business and the same patient adherence/disease management dollars that flow through the Outcomes platform.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights5 records
Customer concentration
Scala Med social profiles
Digital presenceScala Med compliance and trust
Trust signalCompliance1 record
Scala Med financial estimates
Financial estimateRevenue estimate
Valuation estimate
Scala Med leadership team
Management profileNumber of profiles
Profiles1 record
Scala Med funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Scala Med M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Scala Med
What does Scala Med do?
Scala Med (operating as Outcomes) provides a unified clinical pharmacy care ecosystem platform that connects payers, pharmaceutical manufacturers, and providers to a pharmacy network of 48K+ pharmacies and 68K+ practice sites. The platform delivers pharmacy management software (Rx30, ComputerRx), medication therapy management, patient engagement, telepharmacy, virtual verification, immunization registry, and clinical reconciliation tools used to manage dispensing, optimize clinical opportunities, and drive medication adherence across 70M+ patients.
Is Scala Med a public or private company?
Scala Med is a private company. It is classified as venture growth investor backed and is currently operating.
When was Scala Med founded?
Scala Med was founded in 2017. It employs 1 to 10 people.
Where is Scala Med based?
Scala Med is headquartered in Houston, United States, in the North America region.
How does Scala Med make money?
Four revenue lines are on record. Platform/Subscription Revenue is the primary driver. The others are clinical Services Revenue, payer Solutions and pharma Solutions.
Who are Scala Med's main competitors?
Direct peers on record are PioneerRx, BestRx, PrescribeWellness and AdhereHealth. Emerging players are Omnicell and DocStation. Broad incumbents are Surescripts, CoverMyMeds (McKesson), Walgreens Boots Alliance (VillageMD) and CVS Health (Caremark).
Does Scala Med have an API?
No public API is recorded for Scala Med.
What industry is Scala Med in?
Scala Med's product category is Pharmacy Management Software. Its primary akta.pro industry code is HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM), with a secondary code of HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools. Its SIC code is 8000.